• Thursday, Mar 23, 2023
  • Last Update : 10:24 am

Anti-cancer medicine ‘Cyramza’ launched in Bangladesh

  • Published at 02:43 pm October 9th, 2021
Officials of Eli Lilly and Healthcare Pharmaceuticals Limited during the launching event of anti-cancer medicine ‘Cyramza’ at Intercontinental Hotel in Dhaka on Friday, October 8, 2021 Coutesy

The drug is used in the treatment of  cancers of the stomach, lungs, liver or intestines that have spread to other parts of the body

Bangladesh-based ealthcare Pharmaceutical Limited and pharmaceutical company Eli Lilly and Company has launched the popular anti-cancer medicine Cyramza in Bangladesh. 

Cyramza is an anti-cancer medicine that is approved as a single agent and/or in combination with other agents for treatment of cancers of the stomach, lungs, liver or intestines that have spread to other parts of the body, said a press release.

The launch event was held at the Intercontinental Hotel in Dhaka with officials of Eli Lilly and Healthcare Pharmaceuticals Limited in attendance on Friday.

Several prominent doctors of the country were also present at the event. 

Luca Visini, managing director of Eli Lilly and Company India, said: “Cancer impacts the lives of many people every year. We are pleased to bring to Bangladesh an option for the first-line treatment of people with metastatic non-small cell lung cancer [NSCLC] and second-line treatment for people living with the burden of gastric cancer.

“We believe this will help us in moving several steps ahead in our collective goal to make lung and gastric cancer a less formidable challenge and a condition that can be managed,” he added.

Bhupati Kumar Roy, executive director (marketing) of Healthcare Pharmaceuticals Ltd, said they are committed to bringing specialized care for people living with chronic conditions, such as diabetes and cancer, to Bangladesh.

Cyramza plus erlotinib is the first and only US FDA-approved anti-VEGFR/EGFR TKI combination therapy for EGFR-mutated metastatic NSCLC.

Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail